Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,731,208
  • Shares Outstanding, K 289,042
  • Annual Sales, $ 19,372 M
  • Annual Income, $ 1,484 M
  • EBIT $ 2,262 M
  • EBITDA $ 4,550 M
  • 60-Month Beta 0.43
  • Price/Sales 3.45
  • Price/Cash Flow 11.55
  • Price/Book 2.61

Options Overview Details

View History
  • Implied Volatility 28.57% ( +0.97%)
  • Historical Volatility 12.86%
  • IV Percentile 99%
  • IV Rank 98.42%
  • IV High 28.78% on 08/05/24
  • IV Low 15.45% on 08/30/24
  • Put/Call Vol Ratio 3.00
  • Today's Volume 308
  • Volume Avg (30-Day) 425
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 18,296
  • Open Int (30-Day) 18,227

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 3.77
  • Number of Estimates 9
  • High Estimate 3.83
  • Low Estimate 3.74
  • Prior Year 3.42
  • Growth Rate Est. (year over year) +10.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
232.68 +0.71%
on 11/01/24
244.50 -4.16%
on 10/15/24
-3.89 (-1.63%)
since 10/04/24
3-Month
229.31 +2.19%
on 09/11/24
244.98 -4.35%
on 09/03/24
-7.54 (-3.12%)
since 08/02/24
52-Week
218.75 +7.12%
on 07/10/24
259.92 -9.85%
on 11/06/23
-24.58 (-9.49%)
since 11/03/23

Most Recent Stories

More News
Bear of the Day: Align Technology (ALGN)

Align Technology (ALGN) is a Zacks Rank #5 (Strong Sell) that is a global leader in digital orthodontics and the creator of the Invisalign clear aligner system.Align recently reported earnings, with an...

BDX : 234.33 (-0.39%)
ALGN : 210.78 (+1.05%)
Women in Canada Can Now Collect Their Own Sample at Home for Cervical Cancer Screening

/CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today Health Canada approval of the BD...

BDX : 234.33 (-0.39%)
Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

XLV : 146.77 (-0.66%)
$SPX : 5,712.69 (-0.28%)
BDX : 234.33 (-0.39%)
3 Dividend Kings To Buy and Hold in Your Forever Portfolio

These three companies are top choices for a dividend-growth portfolio.

BDX : 234.33 (-0.39%)
TNC : 83.80 (+0.73%)
PH : 638.00 (+0.47%)
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research

Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation...

BSX : 84.72 (+1.32%)
BDX : 234.33 (-0.39%)
BAX : 35.80 (-0.20%)
DVA : 144.94 (+2.37%)
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

Following a slump, shares of Medtronic MDT seem to have started to recuperate, possibly banking on a gradually improving investment and research scenario, thanks to the recent monetary policy easing. Closing...

ABT : 117.65 (-0.80%)
BSX : 84.72 (+1.32%)
BDX : 234.33 (-0.39%)
MDT : 89.31 (-0.84%)
Three Reasons Why You Should Hold BDX Stock in Your Portfolio Now

Becton, Dickinson and Company BDX, popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its solid product portfolio. The optimism led by a solid third-quarter fiscal 2024...

COO : 104.86 (-0.94%)
BSX : 84.72 (+1.32%)
BDX : 234.33 (-0.39%)
DVA : 144.94 (+2.37%)
Baxter Stock: Is BAX Underperforming the Healthcare Sector?

Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

XLV : 146.77 (-0.66%)
CG : 49.06 (-1.72%)
BDX : 234.33 (-0.39%)
BAX : 35.80 (-0.20%)
3 Dividend Aristocrats that Could Double The Dividend

Discover three Dividend Aristocrats poised for dividend growth and long-term returns.

SPGI : 485.77 (+0.51%)
BDX : 234.33 (-0.39%)
WMT : 82.45 (+0.32%)
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including...

ABT : 117.65 (-0.80%)
BSX : 84.72 (+1.32%)
BDX : 234.33 (-0.39%)
MDT : 89.31 (-0.84%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 241.29
2nd Resistance Point 239.35
1st Resistance Point 236.84
Last Price 234.33
1st Support Level 232.40
2nd Support Level 230.46
3rd Support Level 227.95

See More

52-Week High 259.92
Fibonacci 61.8% 244.19
Fibonacci 50% 239.34
Fibonacci 38.2% 234.48
Last Price 234.33
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar